| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: patient-reported outcome results of a randomised phase 3 trial
|
Basch, Ethan
|
|
2013
|
14 |
12 |
p. 1193-1199
7 p.
|
artikel
|
| 2 |
Addressing questions about the HPV vaccine project in India
|
LaMontagne, D Scott
|
|
2013
|
14 |
12 |
p. e492-
1 p.
|
artikel
|
| 3 |
Axitinib dose titration: what's the limiting factor?
|
Buti, Sebastiano
|
|
2013
|
14 |
12 |
p. 1152-1154
3 p.
|
artikel
|
| 4 |
Axitinib with or without dose titration for first-line metastatic renal-cell carcinoma: a randomised double-blind phase 2 trial
|
Rini, Brian I
|
|
2013
|
14 |
12 |
p. 1233-1242
10 p.
|
artikel
|
| 5 |
BEACOPP or no BEACOPP?
|
Federico, Massimo
|
|
2013
|
14 |
12 |
p. e487-e488
nvt p.
|
artikel
|
| 6 |
BEACOPP or no BEACOPP? – Authors' reply
|
Borchmann, Peter
|
|
2013
|
14 |
12 |
p. e488-e489
nvt p.
|
artikel
|
| 7 |
Blue sky days
|
van Dorn, Aaron
|
|
2013
|
14 |
12 |
p. 1163-
1 p.
|
artikel
|
| 8 |
Cancer prevention in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013
|
Lertkhachonsuk, Arb-aroon
|
|
2013
|
14 |
12 |
p. e497-e507
nvt p.
|
artikel
|
| 9 |
Cancer sucks
|
Yaqub, Farhat
|
|
2013
|
14 |
12 |
p. 1164-
1 p.
|
artikel
|
| 10 |
Chemotherapy and resection for colorectal metastases
|
Fong, Yuman
|
|
2013
|
14 |
12 |
p. 1148-1149
2 p.
|
artikel
|
| 11 |
Colon cancer screening provides long-term protection
|
Gilbert, Judith A
|
|
2013
|
14 |
12 |
p. e494-
1 p.
|
artikel
|
| 12 |
Correction to Lancet Oncol 2013; 14: e337
|
|
|
2013
|
14 |
12 |
p. e493-
1 p.
|
artikel
|
| 13 |
Correction to Lancet Oncol 2013; 14: e436
|
|
|
2013
|
14 |
12 |
p. e493-
1 p.
|
artikel
|
| 14 |
Counting the costs of cancer care
|
Lyman, Gary H
|
|
2013
|
14 |
12 |
p. 1142-1143
2 p.
|
artikel
|
| 15 |
Dose-dense effect: other contributors
|
Kesikli, S Altug
|
|
2013
|
14 |
12 |
p. e489-
1 p.
|
artikel
|
| 16 |
Dose-dense effect: other contributors – Author's reply
|
Katsumata, Noriyuki
|
|
2013
|
14 |
12 |
p. e489-e490
nvt p.
|
artikel
|
| 17 |
Dual HER2 targeting for early breast cancer
|
Johnston, Stephen R D
|
|
2013
|
14 |
12 |
p. 1145-1146
2 p.
|
artikel
|
| 18 |
Economic burden of cancer across the European Union: a population-based cost analysis
|
Luengo-Fernandez, Ramon
|
|
2013
|
14 |
12 |
p. 1165-1174
10 p.
|
artikel
|
| 19 |
Etirinotecan pegol: an option for late-stage breast cancer?
|
Nielsen, Dorte L
|
|
2013
|
14 |
12 |
p. 1149-1151
3 p.
|
artikel
|
| 20 |
European Cancer Congress 2013
|
Brierley, Rob
|
|
2013
|
14 |
12 |
p. 1160-
1 p.
|
artikel
|
| 21 |
Evidence-based methods to address disparities in global cancer control: the development of guidelines in Asia
|
Anderson, Benjamin O
|
|
2013
|
14 |
12 |
p. 1154-1155
2 p.
|
artikel
|
| 22 |
Genetics of recurrent medulloblastoma
|
Zollo, Massimo
|
|
2013
|
14 |
12 |
p. 1147-1148
2 p.
|
artikel
|
| 23 |
Genetic variants linked to oesophageal cancer
|
Tanday, Sanjay
|
|
2013
|
14 |
12 |
p. e496-
1 p.
|
artikel
|
| 24 |
Hit-Girl races for life
|
Penny, Helen
|
|
2013
|
14 |
12 |
p. 1162-
1 p.
|
artikel
|
| 25 |
In The Body of The World
|
Astudillo, Olaya
|
|
2013
|
14 |
12 |
p. 1163-1164
2 p.
|
artikel
|
| 26 |
Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial
|
Robidoux, André
|
|
2013
|
14 |
12 |
p. 1183-1192
10 p.
|
artikel
|
| 27 |
Management of adult and paediatric acute lymphoblastic leukaemia in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013
|
Yeoh, Allen E J
|
|
2013
|
14 |
12 |
p. e508-e523
nvt p.
|
artikel
|
| 28 |
Management of B-cell non-Hodgkin lymphoma in Asia: resource-stratified guidelines
|
Tan, Daryl
|
|
2013
|
14 |
12 |
p. e548-e561
nvt p.
|
artikel
|
| 29 |
Management of gastric cancer in Asia: resource-stratified guidelines
|
Shen, Lin
|
|
2013
|
14 |
12 |
p. e535-e547
nvt p.
|
artikel
|
| 30 |
Management of multiple myeloma in Asia: resource-stratified guidelines
|
Tan, Daryl
|
|
2013
|
14 |
12 |
p. e571-e581
nvt p.
|
artikel
|
| 31 |
Management of prostate cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013
|
Williams, Scott
|
|
2013
|
14 |
12 |
p. e524-e534
nvt p.
|
artikel
|
| 32 |
Management of sarcoma in the Asia-Pacific region: resource-stratified guidelines
|
Lewin, Jeremy
|
|
2013
|
14 |
12 |
p. e562-e570
nvt p.
|
artikel
|
| 33 |
Need for change in implementation of paediatric regulation
|
Vassal, Gilles
|
|
2013
|
14 |
12 |
p. 1156-1157
2 p.
|
artikel
|
| 34 |
New gene mutations identified in bladder cancer
|
Marshall, Hilary
|
|
2013
|
14 |
12 |
p. e496-
1 p.
|
artikel
|
| 35 |
Nobel Prizes for 2013: contributions to cancer research
|
Mayor, Susan
|
|
2013
|
14 |
12 |
p. 1159-
1 p.
|
artikel
|
| 36 |
Nuts and cancer: where are we now?
|
Papanastasopoulos, Panagiotis
|
|
2013
|
14 |
12 |
p. 1161-1162
2 p.
|
artikel
|
| 37 |
Onartuzumab benefits patients with MET-positive NSCLC
|
Baker, Holly
|
|
2013
|
14 |
12 |
p. e495-
1 p.
|
artikel
|
| 38 |
Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial
|
Nordlinger, Bernard
|
|
2013
|
14 |
12 |
p. 1208-1215
8 p.
|
artikel
|
| 39 |
Ramucirumab monotherapy for advanced gastric cancer
|
Yaqub, Farhat
|
|
2013
|
14 |
12 |
p. e495-
1 p.
|
artikel
|
| 40 |
Rechallenge of drugs in the era of targeted therapy
|
Nishida, Toshirou
|
|
2013
|
14 |
12 |
p. 1143-1145
3 p.
|
artikel
|
| 41 |
Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis
|
Ramaswamy, Vijay
|
|
2013
|
14 |
12 |
p. 1200-1207
8 p.
|
artikel
|
| 42 |
Resumption of imatinib to control metastatic or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib (RIGHT): a randomised, placebo-controlled, phase 3 trial
|
Kang, Yoon-Koo
|
|
2013
|
14 |
12 |
p. 1175-1182
8 p.
|
artikel
|
| 43 |
Salvage treatment of relapsed or refractory germ-cell tumours
|
De Giorgi, Ugo
|
|
2013
|
14 |
12 |
p. e486-
1 p.
|
artikel
|
| 44 |
Salvage treatment of relapsed or refractory germ-cell tumours – Authors' reply
|
Wessalowski, Rüdiger
|
|
2013
|
14 |
12 |
p. e486-e487
nvt p.
|
artikel
|
| 45 |
Surgery versus SABR for NSCLC
|
Moghanaki, Drew
|
|
2013
|
14 |
12 |
p. e490-e491
nvt p.
|
artikel
|
| 46 |
Surgery versus SABR for NSCLC
|
Louie, Alexander V
|
|
2013
|
14 |
12 |
p. e491-
1 p.
|
artikel
|
| 47 |
The sex hormone system in carriers of BRCA1/2 mutations: a case-control study
|
Widschwendter, Martin
|
|
2013
|
14 |
12 |
p. 1226-1232
7 p.
|
artikel
|
| 48 |
Two schedules of etirinotecan pegol (NKTR-102) in patients with previously treated metastatic breast cancer: a randomised phase 2 study
|
Awada, Ahmad
|
|
2013
|
14 |
12 |
p. 1216-1225
10 p.
|
artikel
|
| 49 |
UK Cancer Drugs Fund receives £400 million boost
|
Marshall, Hilary
|
|
2013
|
14 |
12 |
p. e494-
1 p.
|
artikel
|
| 50 |
Untangling BRCA mutations, sex hormones, and cancer risk
|
Hickey, Martha
|
|
2013
|
14 |
12 |
p. 1151-1152
2 p.
|
artikel
|
| 51 |
US shutdown: not all services are “non-essential”
|
The Lancet Oncology,
|
|
2013
|
14 |
12 |
p. 1141-
1 p.
|
artikel
|
| 52 |
Waiting for prevention in Australia
|
Antill, Yoland
|
|
2013
|
14 |
12 |
p. 1157-1158
2 p.
|
artikel
|
Tijdschrift beschrijving